Marc Beer Loves Helping the Underserved
Marc Beer’s career started with him helping the medically underserved. His first major job as Vice President of Global Marketing for Genzyme made his responsible for promoting product lines for over 7,000 rare diseases. Throughout his career at Genzyme, he reached more than 350 million people who fit into the category of “underserved.”
Inspired by his work with Genzyme, Beer decided to branch out on his own and found ViaCell. ViaCell collected and preserved umbilical cord blood stem cells, which is then used to develop treatments for a variety of conditions. The company was successful within five years and eventually sold for $300 million.
At the height of his career, he suffered a tragic loss. Shortly after selling ViaCell to PerkinElmer, his wife passed away suddenly. Distraught, he ended his entrepreneurial career and only focused on raising his three children. He found solace in being a full-time dad for the rest of his life but that wasn’t his destiny.
Beer would later find inspiration to relaunch his entrepreneurial career from his 14-year-old daughter. She started telling him he needed to “live with purpose;” something he’d been telling her every day for the last two years. Learn more: https://www.crunchbase.com/person/marc-beer
The other half of Beer’s destiny began years before he founded ViaCell. Dr. Ray Iglesias had been performing pelvic floor surgeries for 35 years, and in all that time, he always believed that surgery could be avoided. Before pelvic floor disorders only affect close to 25 percent of the women living in the U.S., most pharmaceutical and biotech companies weren’t developing any therapies or devices.
After 25 years of performing pelvic floor surgeries, he devoted the last ten of his 35-year career to helping women avoid the surgical option. When he finally felt his idea was developed enough, he brought the concept to Marc Beer.
With one phone call, Beer’s career was back on track. Inspired by his daughter and late wife, Beer focused all his effort on helping the women of America. In 2016, the duo brought in Yolanda Lorie and co-founded Renovia, a leader in developing therapeutic and diagnostic devices for women suffering from pelvic floor disorders.
Recently, the company reached its first major milestone by getting one of its products approved by the FDA. Renovia also recently landed some Series B funding in the amount of $32 million. With its first FDA-approved product, Leva, selling, the company also acquired an additional $10 million in revenue for funding.